HORIBA HemeInsights

Newsletter - Issue 4 | August 2025

Morphology Case Study

Patient Details: Female (age not given)

Full Blood Count (FBC) Results:

ParameterValueParameterValue
WBC11.20 (10^3/mm3)MCH29.8 (pg)
RBC2.72* (10^6/mm3)MCHC34.9 (g/dL)
HGB8.1* (g/dL)PLT519* (10^3/mm3)
HCT23.2* (%)RET568 (10^9/L)
MCV55 (fL)

Smear Comment:

Sickle cell anemia. Aniso-poikilocytosis (++). Sickle cells (++). Echinocytes (++). Hypochromic RBCs (++). Reticulocytosis (21%). To note: The white blood cells seem +/- altered. Apoptosis is clearly visible, especially on some images of Polynuclear Neutrophils. The presence of Echinocytes (++). The whole is very evocative of "old" blood and could initially be mistaken as such. However, anemia and the sickle-shaped red blood cells indicate a requirement for hemoglobinopathy investigation.

Microscopic Observations:

Echinocyte: Small projections on red cell membrane.

Sickle red cells: Red blood cells with a sickle shape.

Polynuclear Neutrophils: Varied shapes and sizes of a cell's nucleus (the part of the cell that contains chromosomes). The nuclei of PMNs have two or three lobes with deep divisions.

Aged Sample Effects on a Blood Smear

The Effects of an Aged Blood Sample on Blood Smear Morphology

The quality and interpretability of a blood smear are highly dependent on the freshness of the sample. Aged blood samples—those that have been stored for prolonged periods, especially at room temperature—can introduce a range of artefactual changes that may complicate or compromise hematological interpretation.

1. Morphological Changes in Aged Samples

Over time, cellular components within a blood sample begin to degrade. This degradation is particularly evident in blood smears prepared from samples older than 6–8 hours post-collection. The following artefacts are commonly observed:

Red Blood Cells (RBCs):

  • Increased central pallor, cell distortion, or crenation (echinocytosis).
  • Presence of artefactual spherocytes, making it difficult to differentiate from true spherocytosis.
  • Rouleaux formation may increase due to plasma protein changes or sample drying effects.

White Blood Cells (WBCs):

  • Nuclear degeneration, with pyknotic or smudged nuclei, particularly affecting lymphocytes.
  • Cytoplasmic vacuolation or granule loss in granulocytes.
  • "Basket cells" or "smudge cells" due to cell fragility, especially in lymphocytes.

Platelets:

  • Aggregation is more common in aged samples.
  • Degranulation or loss of platelet definition may occur.

2. EDTA-Induced Artefacts

Ethylenediaminetetraacetic acid (EDTA) is the anticoagulant of choice for most hematological studies. While it is effective at preventing clotting by chelating calcium, EDTA can induce artefacts over time:

  • EDTA-Induced Pseudothrombocytopenia: Platelets may clump in the presence of EDTA, leading to falsely low platelet counts and visible platelet clumps on the smear.
  • Leukoagglutination: Rarely, EDTA can cause white cell clumping.
  • Granular and cytoplasmic changes: Extended exposure to EDTA leads to cytoplasmic vacuolation and nuclear condensation, particularly in neutrophils.
  • RBC Morphology: Prolonged EDTA exposure can cause crenation and distortion of erythrocytes, mimicking pathological forms.

Visual Examples of Age Deterioration

Red cells showing central area of pallor & Rouleaux formation

Crenated & distorted red cells

Platelet aggregation

Conclusion

To ensure accurate morphological interpretation, blood smears should ideally be prepared within 2–4 hours of collection. Delays beyond this window, especially when samples are stored at room temperature, can significantly alter cellular morphology due to both natural degradation and EDTA-induced artefacts. Awareness of these changes is essential for laboratory professionals to distinguish between true pathology and pre-analytical artefacts.

Quiz

What is the best course of action when seeing numerous features as below in the tail of the smear with the following results?

Full Blood Count (FBC) Results:

ParameterValueParameterValue
WBC8.60 (10^3/mm3)MCH29.6 (pg)
RBC3.21 (10^6/mm3)MCHC32.6 (g/dL)
HGB9.5 (g/dL)PLT222* (10^3/mm3)
HCT29.1 (%)RDWsd40.3 (fL)
MCV90.7 (fL)RDWcv12.3 (%)

Options:

  • a) Ignore the features as they are in the tail of the smear.
  • b) Manually check the sample for clots. Comment on the fact that the platelet count may be underestimated and request a repeat.
  • c) Query if Microfilaria is present.

Answers are revealed two weeks after launch—check your inbox, our socials, or the next issue.

Last Issue's Quiz Answer

Question: Name the cell and what may it indicate?

Answer: The cell shown is known as a Band cell or Stab cell; if numerous are present in the blood smear, it is an indicator of infection or inflammation. Gross red cells abnormalities with large platelets and platelet clumps in a Beta Thalassemia patient. Platelet production and their function in hemostasis and infection.

Subscribe to HemeInsights

Subscribe now and get Heme Insights delivered from the next issue!

https://horiba.link/90a885

Editorial Team

Kelly Duffy, Andrew Fisher, HORIBA UK Limited

Contact Information

HORIBA ABX SAS
398 rue du Caducée 34790 Grabels - France
Website: https://www.horiba.com/healthcare
Email: webmaster.med@horiba.com

Read on website: https://horiba.link/6vy

PDF preview unavailable. Download the PDF instead.

Heme Insights 4 August 2025 HORIBA Microsoft PowerPoint pour Microsoft 365

Related Documents

Preview Microsemi Series: Advanced Hematology Analyzers by HORIBA
This report details the HORIBA Microsemi series of automatic blood cell counters, highlighting key technological advancements including cyanide-free lyse, onboard CRP reagent capabilities for the LC-667, and an innovative piercing probe for the LC-661. It also covers the enhanced maintenance support system for improved diagnostics and user experience.
Preview HORIBA C05-LT: 100W PEM Fuel Cell Test Station for Advanced Research
Discover the HORIBA C05-LT, a 100W PEM benchtop test station revolutionizing fuel cell research. Offering precision, repeatability, and advanced safety features for MEA and catalyst development.
Preview Measuring 1 µm PSL Standard with the HORIBA LA-960V2 HL Cell
Application note AN255 detailing the procedure and results for measuring a 1 µm Polystyrene Latex (PSL) standard using the HORIBA LA-960V2 particle size analyzer with the High-concentration Low-viscosity (HL) Cell accessory.
Preview HORIBA Report 2024-2025: Driving Growth and Sustainability
Explore HORIBA's 2024-2025 report detailing their commitment to innovation, sustainability, and creating value through diverse people and technology. Discover their strategies in Energy & Environment, Bio & Healthcare, and Materials & Semiconductor.
Preview HORIBA Report 2024-2025: Driving Innovation for a Sustainable Future
HORIBA's 2024-2025 report detailing its mid-long term management plan (MLMAP2028), corporate strategy, financial performance, sustainability initiatives, and commitment to "Joy and Fun" and "HONMAMON" philosophy across its three focus fields: Energy & Environment, Bio & Healthcare, and Materials & Semiconductor.
Preview HORIBA Report 2024-2025: Driving Growth and Contributing to a Sustainable Society
Explore HORIBA's strategic vision, value creation model, and commitment to addressing global challenges through innovation in energy, environment, bio-healthcare, and advanced materials. Discover HORIBA's 'Honest-to-Goodness' solutions and its dedication to fostering a culture of 'Joy and Fun for All'.
Preview HORIBA Group IP World Cup: Gold Award Winner and Other Recognized Innovations
Explore the 14th HORIBA Group IP World Cup highlights, featuring the Gold Award-winning Chemical Solution Monitoring System and other significant technological advancements recognized for their innovation.
Preview HORIBA, Ltd. Consolidated Financial Statements Summary (Six Months Ended June 30, 2025)
Summary of HORIBA, Ltd.'s consolidated financial results and highlights for the six months ended June 30, 2025, including operating income, net sales, and financial position under Japanese GAAP.